AX-2025-019922
IGF-1 LR3 · 0.1 mg declared · Shanghai Wibson Biotechnology Co., Ltd. · lot SWB-2505-N5257
- Report ID
- AX-2025-019922
- Compound
- IGF-1 LR3
- Compound class
- Growth-hormone axis peptides
- Supplier
- SWB — Shanghai Wibson Biotechnology Co., Ltd.
- Batch / lot
- SWB-2505-N5257
- Declared label claim
- 0.10mg
- Laboratory
- Janoshik Analytical
- Assay date
- 17 Dec 2025
- Submitted
- 29 Dec 2025
- Quarter
- 2025-Q4
- Submitter
- r.lehtinen
- Sample provenance
- Supplier-supplied
Results
Measured against the index acceptance specification for the growth-hormone axis peptides class. A specification is a decision the index made; a result is a measurement. See where each threshold came from.
| Parameter | Method | Result | Unit | Index spec | |
|---|---|---|---|---|---|
| Purity | RP-HPLC, 30 min gradient, 214 nm | 97.33 | % area | ≥ 95.0 | PASS |
| Total impurities | RP-HPLC, sum of reported peaks | 2.67 | % area | ≤ 5.0 | PASS |
| Largest single impurity | RP-HPLC — des-13-residue N-extension (native IGF-1) | 1.40 | % area | ≤ 1.00 | FAIL |
| Identity — theoretical monoisotopic mass | calculated from molecular formula | 9105.2412 | Da | — | NOT TESTED |
| Identity — observed monoisotopic mass | LC-MS, high resolution (ESI-TOF/QTOF) | 9105.2585 | Da | — | NOT TESTED |
| Mass accuracy | observed vs theoretical | +1.9 | ppm | ± 15 | PASS |
| Total peptide content | by difference from the gravimetric mass balance | 87.65 | %w/w | — | NOT TESTED |
| Target-compound content | total peptide content × purity | 85.31 | %w/w | — | NOT TESTED |
| Gross fill (as weighed) | five-place balance, under nitrogen | 0.11 | mg | 0.1 mg declared | NOT TESTED |
| Recovered target peptide | gross fill × target content | 0.094 | mg | 0.1 mg claim | NOT TESTED |
| Recovery against label claim | recovered ÷ claim | 94.0 | % | 90.0 – 110.0 | PASS |
| Water content | Karl Fischer, coulometric, duplicate | 6.54 | % | ≤ 9.0 | PASS |
| Counter-ion (acetate) | anion-exchange ion chromatography | 4.89 | % | ≤ 12.0 | PASS |
| Residual solvent + inorganic residue | estimated — see /methods/residual-solvents-q3c/ | 0.92 | % | — | NOT TESTED |
| Endotoxin | kinetic chromogenic LAL | 0.20 | EU/mg | ≤ 5.0 | PASS |
| Sterility | not ordered on this submission | not determined | — | no growth | NOT TESTED |
| Appearance | visual, diffuse light, black and white background | White lyophilised cake, intact | — | white to off-white intact cake | PASS |
| Reconstitution clarity | reconstituted per submitter procedure | Clear after 90 s gentle swirling, no particulates | — | clear, no visible particulates | PASS |
| pH (reconstituted, 1 mg/mL) | potentiometric, two-point calibration | 6.70 | — | 2.5 – 8.0 | PASS |
| Retention time (observed) | RP-HPLC, 30 min gradient | 16.81 | min | 16.92 ± 0.50 (normalised) | PASS |
| Peak asymmetry (10 % height) | Ph. Eur. 2.2.46 | 1.22 | — | 0.80 – 1.50 | PASS |
| Plate count, main peak | N = 5.54 (t/w½)² | 63,699 | — | ≥ 20,000 | PASS |
| Resolution to nearest impurity | vs disulfide-scrambled isomer | 2.27 | — | no index criterion | REPORTED |
Chromatogram and peak integration
The figure is drawn from the table. It is not an independent illustration — if a number in the table changed, the trace would change with it.
| # | Peak | RT | Area (µV·s) | % area | Δ mass (Da) |
|---|---|---|---|---|---|
| 1 | IGF-1 LR3 — main peak | 16.81 | 4,730,540 | 97.33 | — |
| 2 | des-13-residue N-extension (native IGF-1) | 14.57 | 68,044 | 1.40 | -1441.712 |
| 3 | disulfide-scrambled isomer | 17.43 | 25,760 | 0.53 | 0.000 |
| 4 | truncated (1-70) | 14.87 | 20,413 | 0.42 | -1385.688 |
| 5 | oxidised Met59 (+16 Da) | 16.09 | 8,749 | 0.18 | +15.995 |
| 6 | aggregated dimer | 20.01 | 6,804 | 0.14 | +9105.241 |
| Closure check — purity + Σ impurities | 100.00 | CLOSES | |||
Reporting threshold 0.05 % area. Peaks below it are not reported and are therefore excluded from the total, which overstates purity by their sum — see peak integration.
Mass spectrum and identity
Theoretical monoisotopic mass 9105.2412 Da, computed from C400H625N111O116S9. All ppm figures on this site are against monoisotopic values — see why that matters.
| Charge | Theoretical m/z | Observed m/z | Δ m/z | Rel. abundance (%) |
|---|---|---|---|---|
| 11+ | 828.7565 | 828.7580 | 0.0015 | 8.1 |
| 10+ | 911.5314 | 911.5331 | 0.0017 | 56.8 |
| 9+ | 1012.7007 | 1012.7027 | 0.0020 | 100.0 |
| 8+ | 1139.1624 | 1139.1646 | 0.0022 | 54.2 |
| 7+ | 1301.7560 | 1301.7585 | 0.0025 | 7.9 |
Gravimetric mass balance
Water, counter-ion, residual and total peptide content are exhaustive and mutually exclusive categories. They must account for 100 % of the cake mass. The index closes this to within 0.02 pp and the build asserts it.
| Component | Determination | %w/w of cake |
|---|---|---|
| Water | Karl Fischer | 6.54 |
| Counter-ion (acetate) | ion chromatography | 4.89 |
| Residual solvent + inorganic residue | estimated | 0.92 |
| Total peptide content | by difference | 87.65 |
| Total | 100.00 CLOSES | |
Supplier certificate, as declared
The supplier's own figures for this lot, beside the independent measurement. Divergence is assessed against the batch median, not against this single report — see rule AX-R05.
| Figure | Supplier COA | This report | Index note |
|---|---|---|---|
| Purity (% area) | 97.40 | 97.33 | divergence +0.40 pp vs batch median |
| Total impurities (% area) | not stated | 2.67 | |
| Largest single impurity (% area) | not stated | 1.40 | |
| Water (%) | 5.3 | 6.54 | |
| Counter-ion (%) | 5.9 | 4.89 | |
| Peptide content (%w/w) | 88.2 | 87.65 | |
| Endotoxin (EU/mg) | 0.29 | 0.20 | |
| Method stated on certificate | YES | — | column, gradient and wavelength given |
Provenance and caveats
Where a sample came from changes the weight of the evidence. The index treats it as a first-class field.
- Sample provenance
- Supplier-supplied
- Evidentiary weight
- Weaker evidence. Read with the caveat below.
- Chain of custody
- Supplier despatch → laboratory direct (courier, cold pack, 9 d) → assay. Submitter did not handle the vial.
- Assay date
- 17 Dec 2025
- Submitted to the index
- 29 Dec 2025
- Laboratory
- Janoshik Analytical, Ostrava, Czechia
- Method basis
- 30 min gradient · high-resolution MS
- Verification status
- VERIFIED
Annotations
No annotations on this record. Annotations are short signed technical comments from index contributors; see how to contribute.
Related records
Same batch — lot SWB-2505-N5257 n=11
| Report | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|
| AX-2025-019919 | SWB-2505-N5257 | VendorInvestigate | 2025-Q4 | 96.62 | 6.89 | — | Buyer-sourced | 0 | PASS |
| AX-2025-019920 | SWB-2505-N5257 | Medutest | 2025-Q4 | 97.38 | 6.59 | 102.0 | Supplier-supplied | 0 | PASS |
| AX-2025-019921 | SWB-2505-N5257 | Janoshik | 2025-Q4 | 97.03 | 6.49 | 111.0 | Laboratory-retained | 1 | MARGINAL |
| AX-2025-019923 | SWB-2505-N5257 | Kestrel | 2025-Q4 | 96.83 | 6.36 | — | Supplier-supplied | 0 | PASS |
| AX-2025-019924 | SWB-2505-N5257 | VendorInvestigate | 2025-Q4 | 96.06 | 6.70 | — | Buyer-sourced | 0 | PASS |
| AX-2025-019925 | SWB-2505-N5257 | Nordanalyt | 2025-Q4 | 97.00 | 6.94 | — | Supplier-supplied | 0 | PASS |
| AX-2025-019926 | SWB-2505-N5257 | Janoshik | 2025-Q4 | 96.90 | 6.74 | — | Supplier-supplied | 0 | PASS |
| AX-2025-019927 | SWB-2505-N5257 | Janoshik | 2025-Q4 | 96.95 | 6.20 | 101.0 | Supplier-supplied | 0 | PASS |
| AX-2025-019928 | SWB-2505-N5257 | Janoshik | 2025-Q4 | 97.13 | 7.00 | 101.0 | Supplier-supplied | 0 | PASS |
| AX-2025-019929 | SWB-2505-N5257 | Janoshik | 2025-Q4 | 97.17 | 6.54 | — | Supplier-supplied | 0 | PASS |
Cross-sections
| Report | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-042238 | Homopeptide | HOMO-2607-P1246 | PeptideMeter | 2026-Q3 | 98.34 | 6.38 | 95.0 | Laboratory-retained | 0 | PASS |
| AX-2026-042639 | GGPeps | GGPE-2604-K8140 | Janoshik | 2026-Q2 | 98.11 | 2.57 | 88.0 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-043299 | CPC | CPC-2512-S2394 | VendorInvestigate | 2026-Q2 | 97.29 | 1.77 | 96.7 | Buyer-sourced | 1 | FAIL |
| AX-2026-043296 | CPC | CPC-2512-S2394 | VendorInvestigate | 2026-Q2 | 97.80 | 2.30 | 91.3 | Buyer-sourced | 0 | PASS |
| AX-2026-042636 | GGPeps | GGPE-2604-K8140 | Janoshik | 2026-Q2 | 98.39 | 2.26 | — | Supplier-supplied | 0 | PASS |
| AX-2026-042642 | GGPeps | GGPE-2604-K8140 | Janoshik | 2026-Q2 | 98.18 | 2.54 | — | Supplier-supplied | 0 | PASS |
| AX-2026-043291 | CPC | CPC-2512-S2394 | PeptideMeter | 2026-Q2 | 98.18 | 2.74 | 99.7 | Supplier-supplied | 0 | PASS |
| AX-2026-042643 | GGPeps | GGPE-2604-K8140 | Janoshik | 2026-Q2 | 98.10 | 2.36 | 109.0 | Laboratory-retained | 0 | PASS |
| Report | Compound | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-042461 | Kisspeptin-10 | SWB-2603-D6238 | Janoshik | 2026-Q3 | 98.35 | 4.65 | 96.5 | Supplier-supplied | 3 | FAIL |
| AX-2026-042479 | Melanotan II | SWB-2603-A5707 | Janoshik | 2026-Q3 | 99.16 | 3.67 | 94.5 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042481 | Melanotan II | SWB-2603-A5707 | Medutest | 2026-Q3 | 98.95 | 3.37 | 90.8 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042460 | Kisspeptin-10 | SWB-2603-D6238 | Kestrel | 2026-Q3 | 99.55 | 4.21 | 90.8 | Supplier-supplied | 3 | MARGINAL |
| AX-2026-042483 | Melanotan II | SWB-2603-A5707 | Janoshik | 2026-Q3 | 99.38 | 3.73 | 107.2 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042398 | Semaglutide | SWB-2602-X5278 | Nordanalyt | 2026-Q3 | 99.08 | 4.48 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042399 | Semaglutide | SWB-2602-X5278 | Janoshik | 2026-Q3 | 98.56 | 3.82 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042499 | BPC-157 | SWB-2607-Y5787 | Kestrel | 2026-Q3 | 99.93 | 4.25 | 94.4 | Supplier-supplied | 0 | PASS |